๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Intrahepatic Cholangiocarcinoma

Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma NCT06721286Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Teripalimab, Gemcitabine + Cisplatin, Surgery Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma NCT06462742n/a1 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: Microwave ablation (MWA) versus Liver Resection (LR) A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC NCT06925516Phase 21 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: Apatinib and Adebrelimab in Combination With chemotherapy GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence NCT05557578Phase 22 sites๐Ÿ“ Hangzhou๐Ÿ“ Hanzhou Zhejiang Cancer Hospital ยท Tests: Tislelizumab combined with GEMOX (GOT) regimen Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy NCT07201519Phase 21 site๐Ÿ“ Lexington Michael J Cavnar, MD ยท Tests: Hepatic Artery Infusion Pump (HAIP), Standard Treatment, Community Treatment, Systemic Chemotherapy Standard of Care, Sโ€ฆ REGULUS: MRI-guided Adaptive SABR for Liver Cancers NCT07223307Phase 21 site๐Ÿ“ Palo Alto Stanford University ยท Tests: MRI-guided adaptive stereotactic ablative body radiotherapy (SABR) Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III) NCT07161869n/a6 sites๐Ÿ“ Rotterdam๐Ÿ“ Amsterdam๐Ÿ“ Groningen Erasmus Medical Center ยท Tests: Registration of all findings during preoperative Endoscopic Ultrasound Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma NCT06664021Phase 22 sites๐Ÿ“ Fuyang๐Ÿ“ Hefei Anhui Provincial Hospital ยท Tests: Tislelizumab combined with S-1 A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4ฮฑ srRNA in Treating Advanced ICC Patients NCT06583993EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Changzheng Hospital ยท Tests: HNF4ฮฑ srRNA An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer NCT06342414n/a5 sites๐Ÿ“ Duarte๐Ÿ“ Fukuoka๐Ÿ“ Kumamoto City of Hope Medical Center ยท Tests: ELUCIDATE Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma NCT06746480Phase 21 site๐Ÿ“ Hangzhou CNBG-Virogin Biotech (Shanghai) Ltd. ยท Tests: Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)) A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma NCT05967182Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Pembrolizumab, Gemcitabine, Cisplatin Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer NCT03942328Phase 1, Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Atezolizumab, Bevacizumab, External Beam Radiation Therapy, Pheresis, Pneumococcal 13-valent Conjugate Vaccine Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial) NCT04556214NA1 site๐Ÿ“ Oslo Oslo University Hospital ยท Tests: Liver Transplant A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma NCT05678270Phase 244 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Beijing Beijing InnoCare Pharma Tech Co., Ltd. ยท Tests: ICP-192 Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma NCT04299581Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: Camrelizumab, US/CT-guided Percutaneous Cryoablation Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study NCT07640048n/a1 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Adebrelimab, Gemcitabine, Cisplatin, S-1, Apatinib Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer NCT06280508Phase 21 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: Adebrelimab, Apatinib, Gemcitabine, cisplatin Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer NCT05265208Phase 27 sites๐Ÿ“ Rennes๐Ÿ“ Pessac๐Ÿ“ Montpellier Center Eugene Marquis ยท Tests: Capecitabine, Selective Internal Radiotherapy (SIRT), Surgery A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma NCT07063888Phase 21 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Adjuvant Concurrent Chemoradiotherapy with Simultaneous Integrated Boost Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer NCT07641036Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-HC01 dual-target CARNK cells, Fludarabine, Cyclophosphamide D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC NCT06643208n/a1 site๐Ÿ“ Fuzhou Fujian Provincial Hospital ยท Tests: TACE-HAIC, Envafolimab and Lenvatinib Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study NCT05342194Phase 31 site๐Ÿ“ Shanghai Shanghai Junshi Bioscience Co., Ltd. ยท Tests: Toripalimab, Lenvatinib mesylate capsules, Placebo IV, Oral placebo, Oxaliplatin for injection Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial) NCT06859684Phase 21 site๐Ÿ“ Chengdu West China Hospital ยท Tests: Durvalumab, hepatic arterial infusion chemotherapy (HAIC), Lenvatinib Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma NCT04078230NA13 sites๐Ÿ“ Baltimore๐Ÿ“ Beijing๐Ÿ“ Beijing Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: Extend LymphAdenectomy Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments NCT06862934n/a1 site๐Ÿ“ Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases NCT05285358Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Cisplatin, Gemcitabine, Nab-paclitaxel, Quality-of-Life Assessment, Questionnaire Administration HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma NCT06858735Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Durvalumab, Gemcitabine, Cisplatin Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-ฮฒ Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II Trial NCT07847710Phase 21 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Retlirafusp alfa, Famitinib malate, Gemcitabine & oxaliplatin, Capecitabine, S-1 Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma NCT06956716Phase 1, Phase 21 site๐Ÿ“ Hangzhou Zhejiang University ยท Tests: individualized anti-tumor new antigen iNeo-Vac-R01 injection, Gemcitabine + cisplatin (GP), Sintilimab injection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy